568 related articles for article (PubMed ID: 17961019)
1. National trends, complications, and outcomes following transsphenoidal surgery for Cushing's disease from 1993 to 2002.
Patil CG; Lad SP; Harsh GR; Laws ER; Boakye M
Neurosurg Focus; 2007; 23(3):E7. PubMed ID: 17961019
[TBL] [Abstract][Full Text] [Related]
2. Demographic factors, outcomes, and patient access to transsphenoidal surgery for Cushing's disease: analysis of the Nationwide Inpatient Sample from 2002 to 2010.
Wilson D; Jin DL; Wen T; Carmichael JD; Cen S; Mack WJ; Zada G
Neurosurg Focus; 2015 Feb; 38(2):E2. PubMed ID: 25639320
[TBL] [Abstract][Full Text] [Related]
3. Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease.
Patil CG; Veeravagu A; Prevedello DM; Katznelson L; Vance ML; Laws ER
Neurosurgery; 2008 Aug; 63(2):266-70; discussion 270-1. PubMed ID: 18797356
[TBL] [Abstract][Full Text] [Related]
4. National inpatient complications and outcomes after surgery for spinal metastasis from 1993-2002.
Patil CG; Lad SP; Santarelli J; Boakye M
Cancer; 2007 Aug; 110(3):625-30. PubMed ID: 17577227
[TBL] [Abstract][Full Text] [Related]
5. Transsphenoidal surgery for Cushing's disease: a review of success rates, remission predictors, management of failed surgery, and Nelson's Syndrome.
Kelly DF
Neurosurg Focus; 2007; 23(3):E5. PubMed ID: 17961026
[TBL] [Abstract][Full Text] [Related]
6. Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas.
Fomekong E; Maiter D; Grandin C; Raftopoulos C
Clin Neurol Neurosurg; 2009 Jun; 111(5):442-9. PubMed ID: 19200645
[TBL] [Abstract][Full Text] [Related]
7. Safety of transsphenoidal microsurgical approach in patients with an ACTH-secreting pituitary adenoma.
Donofrio CA; Losa M; Gemma M; Giudice L; Barzaghi LR; Mortini P
Endocrine; 2017 Nov; 58(2):303-311. PubMed ID: 28005257
[TBL] [Abstract][Full Text] [Related]
8. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease.
Flitsch J; Knappe UJ; Lüdecke DK
Zentralbl Neurochir; 2003; 64(1):6-11. PubMed ID: 12582940
[TBL] [Abstract][Full Text] [Related]
9. Complications after transsphenoidal surgery for patients with Cushing's disease and silent corticotroph adenomas.
Smith TR; Hulou MM; Huang KT; Nery B; de Moura SM; Cote DJ; Laws ER
Neurosurg Focus; 2015 Feb; 38(2):E12. PubMed ID: 25639314
[TBL] [Abstract][Full Text] [Related]
10. Effects of age and comorbidities on complication rates and adverse outcomes after lumbar laminectomy in elderly patients.
Li G; Patil CG; Lad SP; Ho C; Tian W; Boakye M
Spine (Phila Pa 1976); 2008 May; 33(11):1250-5. PubMed ID: 18469700
[TBL] [Abstract][Full Text] [Related]
11. Repeated transsphenoidal pituitary surgery (TS) via the endoscopic technique: a good therapeutic option for recurrent or persistent Cushing's disease (CD).
Wagenmakers MA; Netea-Maier RT; van Lindert EJ; Timmers HJ; Grotenhuis JA; Hermus AR
Clin Endocrinol (Oxf); 2009 Feb; 70(2):274-80. PubMed ID: 18616702
[TBL] [Abstract][Full Text] [Related]
12. Inpatient Complications After Transsphenoidal Surgery in Cushing's Versus Non-Cushing's Disease Patients.
Svider PF; Raikundalia MD; Pines MJ; Baredes S; Folbe AJ; Liu JK; Eloy JA
Ann Otol Rhinol Laryngol; 2016 Jan; 125(1):5-11. PubMed ID: 26180176
[TBL] [Abstract][Full Text] [Related]
13. Single-center experience with pediatric Cushing's disease.
Kanter AS; Diallo AO; Jane JA; Sheehan JP; Asthagiri AR; Oskouian RJ; Okonkwo DO; Sansur CA; Vance ML; Rogol AD; Laws ER
J Neurosurg; 2005 Nov; 103(5 Suppl):413-20. PubMed ID: 16302612
[TBL] [Abstract][Full Text] [Related]
14. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.
Acebes JJ; Martino J; Masuet C; Montanya E; Soler J
Acta Neurochir (Wien); 2007; 149(5):471-7; discussion 477-9. PubMed ID: 17406780
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic transsphenoidal treatment of hormonally active pituitary adenomas.
Rudnik A; Kos-Kudła B; Larysz D; Zawadzki T; Bazowski P
Neuro Endocrinol Lett; 2007 Aug; 28(4):438-44. PubMed ID: 17693972
[TBL] [Abstract][Full Text] [Related]
16. Outcomes and management of patients with Cushing's disease without pathological confirmation of tumor resection after transsphenoidal surgery.
Pouratian N; Prevedello DM; Jagannathan J; Lopes MB; Vance ML; Laws ER
J Clin Endocrinol Metab; 2007 Sep; 92(9):3383-8. PubMed ID: 17595252
[TBL] [Abstract][Full Text] [Related]
17. Current state of the art in the diagnosis and surgical treatment of Cushing disease: early experience with a purely endoscopic endonasal technique.
Dehdashti AR; Gentili F
Neurosurg Focus; 2007; 23(3):E9. PubMed ID: 17961027
[TBL] [Abstract][Full Text] [Related]
18. Intra- and postoperative plasma ACTH concentrations in patients with Cushing's disease cured by transsphenoidal pituitary surgery.
Czirják S; Bezzegh A; Gál A; Rácz K
Acta Neurochir (Wien); 2002 Oct; 144(10):971-7; discussion 977. PubMed ID: 12382124
[TBL] [Abstract][Full Text] [Related]
19. Management of Cushing's disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging.
Prevedello DM; Pouratian N; Sherman J; Jane JA; Vance ML; Lopes MB; Laws ER
J Neurosurg; 2008 Oct; 109(4):751-9. PubMed ID: 18826366
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing's disease.
Rollin G; Ferreira NP; Czepielewski MA
Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1355-61. PubMed ID: 18209874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
